Skip to main content
. 2022 Oct 9;23(19):11990. doi: 10.3390/ijms231911990

Figure 2.

Figure 2

MAPK pathway (left) and immunosuppressive role of KRAS (right) mediated by upregulation of PDL-1, increased Tregs and MDSCs in TME, and downregulation of MHC-I.